FTSE All-Share

FTSE All-Share handeln
5.598,85 PKT +55,76 PKT +1,01 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
16.10.19 Rio Tinto buy Goldman Sachs Group Inc.
16.10.19 Rio Tinto Hold Deutsche Bank AG
16.10.19 Rio Tinto Underperform Credit Suisse Group
15.10.19 Unilever Outperform Credit Suisse Group
15.10.19 Unilever kaufen Credit Suisse Group
15.10.19 Lloyds Banking Group buy UBS AG
15.10.19 National Grid Outperform RBC Capital Markets
15.10.19 HSBC Neutral UBS AG
15.10.19 Glencore buy HSBC
15.10.19 Barclays buy UBS AG
15.10.19 Rio Tinto buy HSBC
15.10.19 AstraZeneca Hold Jefferies & Company Inc.
15.10.19 Rio Tinto Underperform Credit Suisse Group
14.10.19 BP Neutral Credit Suisse Group
14.10.19 Lloyds Banking Group Outperform RBC Capital Markets
14.10.19 HSBC buy Goldman Sachs Group Inc.
14.10.19 AstraZeneca overweight JP Morgan Chase & Co.
14.10.19 Lloyds Banking Group Neutral JP Morgan Chase & Co.
14.10.19 Barclays overweight JP Morgan Chase & Co.
11.10.19 Rio Tinto overweight JP Morgan Chase & Co.
11.10.19 BP Outperform RBC Capital Markets
11.10.19 BP Conviction Buy List Goldman Sachs Group Inc.
11.10.19 Glencore overweight Barclays Capital
11.10.19 London Stock Exchange (LSE) Hold HSBC
11.10.19 Rio Tinto buy Jefferies & Company Inc.
10.10.19 Unilever Neutral UBS AG
10.10.19 Unilever Neutral UBS AG
10.10.19 Unilever Hold HSBC
10.10.19 BP Neutral Credit Suisse Group
10.10.19 Rio Tinto buy HSBC
09.10.19 Vodafone Group buy UBS AG
09.10.19 Glencore Neutral UBS AG
09.10.19 Diageo market-perform Bernstein Research
09.10.19 HSBC Underweight Morgan Stanley
09.10.19 London Stock Exchange (LSE) overweight JP Morgan Chase & Co.
09.10.19 Vodafone Group buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
08.10.19 Prudential Outperform Credit Suisse Group
08.10.19 Vodafone Group overweight JP Morgan Chase & Co.
08.10.19 AstraZeneca overweight JP Morgan Chase & Co.
08.10.19 Prudential Neutral JP Morgan Chase & Co.